Fair call.
You seem to know a fair bit more than me about this and I appreciate your informed posts.
Those variances in recoveries in the table you posted - do they look pretty standard for a system that's in early stage production? Is it fair to expect that with the normal 'tweaking' they'll narrow/eliminate those variances?
- Forums
- ASX - By Stock
- STA
- Ann: Quarterly Activities and Cashflow Report
Ann: Quarterly Activities and Cashflow Report, page-23
-
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add STA (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $138.9M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
STA (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online